ARCHIVES

Pediatric CCP Controversy Splits Group Leaders; National Consortium Forms; NCAB to Watch Closely

This article is from The Cancer Letter archive.

Vol. 09 No. 02 | January 14, 1983

Download PDF Visit The Full Archive

Related Articles

FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says.

April 1, 2005

United Approach With Other Health Advocates Needed To Increase Cancer Dollars, Royboal Says

February 10, 1978

Named VP, Health sciences At UNM

February 11, 1994

Heavy Smokers And Drinkers Have Different Brain Chemistry

May 30, 2003

Cooperative Groups Other Investigators To Get Interferon When Available; DCT Recompetitions Okayed

April 4, 1980

Nine contracts For Automated Pap Test Systems Total $1.7 Million

October 18, 1974